fbpx

Regulations

Viewpoint on the pharmaceutical industry’s promotional spending

The promotional activities of pharmaceutical companies are regularly the target of criticism. Certain commentators imply that these businesses as a group devote too many resources to the promotion of their products, at the expense of their investments in research and development (R&D). Others maintain that these promotional activities alter the prescribing habits of doctors, which leads to a needless or even harmful rise in the consumption of drugs. Do these criticisms stand up to scrutiny?

Plain Packaging and its Unintended Consequences

This Economic Note is the second in a series on the growing tendency of governments around the world to regulate the advertising industry more and more strictly. Whether in the name of consumer protection or health concerns, decision makers prefer to attack advertising for products deemed harmful rather than prohibiting them directly.

Back to top